Bug - no I am saying there is no way a company this small could (well that’s what I am told anyway - I’m also learning about ANP and wondering how they can do it so maybe it is not as expensive as I was led to believe).
Taking Tonys posts they seem to be focusing on the ability to be tissue specific and add that to all the messaging from the company since the current CEO/Chairman combination took control and it is all about BIG deals not small ones. The impression I get (I think comments from the guys who went to the AGM) is that Tribe is playing for min 10m upfronts or 250m+ buyout. They might get smaller deals but that would be from the 2nd priority targets.
They just raised enough money to go well into 2020 but keep talking about mid 2019. I think they are setting it up for a run at the clinic in 2020 via a big international funding round (primed people In Asia late last year) but also to be bought out before then if someone is interested. We should have a much better idea in Q2 and the action would be soon after that.
I might be just trying to fit this into my timetable - I am coming up to a year in Q2 and am down a little so could be desperation in my reading.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |